论文部分内容阅读
胰腺癌是一种高度恶性的消化道肿瘤,尽管以手术为主的胰腺癌综合治疗模式在延长患者生存时间和提高生活质量方面取得了一定进展,但其临床疗效仍不尽人意。资料显示胰腺癌术后5年生存率仅为3%～4%。面对严峻的现实,惟有多学科交叉合作,在胰腺癌发病机制、早期诊断、综合治疗等方面进行深入研究,并获得突破性进展,才有望根本改善其预后。
Although pancreatic cancer is a highly malignant gastrointestinal tumor, although the overall surgical model of pancreatic cancer has made some progress in prolonging survival and improving quality of life, its clinical efficacy is still not satisfactory. Data show that 5-year survival rate of pancreatic cancer after surgery was only 3% to 4%. Faced with the harsh reality, only multidisciplinary cross-cooperation, in the pathogenesis of pancreatic cancer, early diagnosis, comprehensive treatment and other aspects of in-depth study and access to breakthroughs, it is expected to fundamentally improve its prognosis.